Work Connected with the Olympus Scientific Cloud
24.10.2017 17:00:00 EEST | Business Wire | Press release
The new Olympus Scientific Cloud expands the capabilities of the EPOCH® 6LT flaw detector and Vanta™ handheld XRF analyzer at no extra cost, with more features planned in the coming months. A suite of new capabilities, including wireless software updates, easy data backups, and real-time screen sharing for Vanta analyzers help make your work faster and more efficient.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171024005101/en/
Work Connected with the Olympus Scientific Cloud (Photo: Business Wire)
Olympus is constantly improving the software of our instruments. The Olympus Scientific Cloud (OSC) enables users to wirelessly download the latest software updates directly to their instrument without having to use a PC interface program. When an update for the Vanta analyzer is available, a notification will appear in the device’s user interface, prompting the user to download. EPOCH 6LT users can check the Cloud web application for updates. For fleet managers, this functionality helps ensure that all of the EPOCH 6LT flaw detectors and Vanta analyzers in their fleet are operating on the same software version for reliable, reproducible results.
Once data has been acquired, the Olympus Scientific Cloud makes it easy to back it up and share it with others. Operators can wirelessly upload their data to the Cloud, even while they are still in the field. Users no longer have to worry about maintaining a large backlog of files on their instrument or running out of space. Once the data is in the Cloud, colleagues back in the office or on the other side of the world can see the data for fast, efficient collaboration. The data files can also be transferred in open formats, like CSV, so users can easily access their data using their preferred software.
The OSC has powerful new management functionality. Fleet managers can monitor health parameters of their devices, such as active time, error logs, and temperature.* Managers can also use the OSC to keep track of how much each device is used to help ensure that the work is distributed evenly across the fleet. If an instrument needs to be serviced, the Cloud helps the Olympus service center know what components and software need updating or servicing to minimize downtime.
For Vanta analyzers, the OSC offers additional benefits, including:
- Screen sharing: users in the field can share their analyzer’s screen with decision-makers back in the office.
- Advanced fleet management: managers can track the last reported physical location of all of their analyzers.
- Automatic data uploads: data automatically uploads (or is sent) to the Cloud as soon as you complete a test.
The benefits and functionality of the Olympus Scientific Cloud are paired with leading-edge security features. With a network of data centers located all over the world, users can be assured that their data is stored securely and locally. All data uploaded to the Olympus Scientific Cloud remains the property of the customer; Olympus does not share or use customer data that is stored in the Cloud.
*Health data varies per instrument.
About Olympus
Olympus Corporation operates in industrial, medical, and consumer markets, specializing in optics, electronics, and precision engineering. Olympus is a world-leading manufacturer of innovative test and measurement solutions that are used in industrial and research applications ranging from aerospace, power generation, petrochemical, civil infrastructure, and automotive to consumer products.
For more information about the Olympus Scientific Cloud and Olympus’ full line of nondestructive testing products, contact a sales representative or visit http://www.olympus-ims.com/.
Olympus and EPOCH are registered trademarks, and Vanta is a trademark of Olympus Corporation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171024005101/en/
Contact information
Olympus Corporation
Calvin Jory, 781-419-3549
Calvin.Jory@olympus-ossa.com
or
Michelle
Wright, 781-419-3664
Michelle.Wright@olympus-ossa.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom